Metabolic Syndrome and Nephrolithiasis; A Cross Sectional Population-based Study on the Baseline Data of the PERSIAN Kavar Cohort Study

• DOI: 10.1016/j.urology.2022.11.004
• Publication Date: 2022-11-23T18:50:18Z
• Authors: Sara Shojaei-Zarg...; Ali Reza Safarpour; Hassan Askari; Hossein Kargar Ja...; Elham Abbasi; Mohammad Reza Fat...
• Keywords: Metabolic Syndrome; Hypertriglyceridemia; 3. Good health; Cohort Studies; Kidney Calculi; 03 medical and health sciences; Cross-Sectional Studies; 0302 clinical medicine; Risk Factors; Hypertension; Prevalence; Humans; Prospective Studies; Aged

To explore the relationship between metabolic syndrome and its components with nephrolithiasis.In current study, 4,901 individuals from the PERSIAN (Prospective Epidemiological Research Studies in IrAN) Kavar cohort study were included. Metabolic syndrome was defined according to the ATP III criteria (2005 revision). The nephrolithiasis was assessed using a structured questionnaire, and ultrasound findings were reviewed in subjects who reported positive history of nephrolithiasis. We applied logistic regression to estimate the odds ratio (OR) and 95% confidence interval (CI).The prevalence of nephrolithiasis and metabolic syndrome was 28.5% and 40.91%, respectively. Almost 31% of the patients with metabolic syndrome had a history of nephrolithiasis. Multivariable logistic regression analysis revealed a positive association between metabolic syndrome and nephrolithiasis (OR= 1.30, 95% CI: 1.14-1.49, P<.001) after adjustment age, sex, ethnicity, physical activity, smoking status, and alcohol intake. Furthermore, the relation was higher for elders aged 50 years or more (P for interaction= .016) and Turk Nomad participants (P for interaction= 0.044) than the others. There was also a positive independent association between hypertension (OR=1.29, 95% CI: 1.12-1.48, P<.001) and hypertriglyceridemia (OR= 1.15, 95% CI: 1.01-1.31, P=.033) with nephrolithiasis.In this large sample study, we demonstrate a weak positive association between metabolic syndrome, hypertension, and hypertriglyceridemia with nephrolithiasis.